產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-ERV31抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ERV31抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ERV31
Cat. Number:
Anti-ERV31抗體KL-14631R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Retroviral envelope proteins Anti-ERV31抗體mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its fusogenic properties. It can inhibit cell growth through decrease expression of cyclin B1 and increased expression of p21 in vitro. SU mediates receptor recognition.
TM anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane.
TM anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane.
Also known as:
Endogenous retroviral sequence 3;Anti-ERV31抗體 Endogenous retrovirus group 3 member 1; ENR1_HUMAN; Envelope polyprotein; envR; ERV R; ERV-3 envelope protein; ERV-R envelope protein; ERV3 1 envelope protein; ERV3; ERV3 envelope protein; ERV3-1; ERVR; FLJ23884; HERV R; HERV-R envelope protein; HERV-R_7q21.2 provirus ancestral Env polyprotein; HERVR; SU; TM; Transmembrane protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .Anti-ERV31抗體
●
Immunogen: KLH conjugated synthetic peptide derived from human ERV31.
●
Predicted Molecular Weight: 68kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 Anti-ERV31抗體
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl626Mu01 胱天蛋白酶3(CASP3)多克隆抗體 Polyclonal Antibody to Caskle 3 (CASP3)
kl626Ra01 胱天蛋白酶3(CASP3)多克隆抗體 Polyclonal Antibody to Caskle 3 (CASP3)
kl627Hu01 胱天蛋白酶9(CASP9)多克隆抗體 Polyclonal Antibody to Caskle 9 (CASP9)
kl627Mu01 胱天蛋白酶9(CASP9)多克隆抗體 Polyclonal Antibody to Caskle 9 (CASP9)
kl627Ra01 胱天蛋白酶9(CASP9)多克隆抗體 Polyclonal Antibody to Caskle 9 (CASP9)
kl628Hu01 一氧化氮合酶運(yùn)輸因子(NOSTRIN)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase Trafficker (NOSTRIN)
kl628Ra01 一氧化氮合酶運(yùn)輸因子(NOSTRIN)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase Trafficker (NOSTRIN)
kl629Hu01 BH3相互作用域死亡激動(dòng)劑(Bid)多克隆抗體 Polyclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
kl629Mu01 BH3相互作用域死亡激動(dòng)劑(Bid)多克隆抗體 Polyclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
kl629Ra01 BH3相互作用域死亡激動(dòng)劑(Bid)多克隆抗體 Polyclonal Antibody to BH3 Interacting Domain Death Agonist (Bid)
kl630Hu01 糖原合酶激酶3α(GSK3α)多克隆抗體 Polyclonal Antibody to Glycogen Synthase Kinase 3 Alpha (GSK3a)
kl630Ra01 糖原合酶激酶3α(GSK3α)多克隆抗體 Polyclonal Antibody to Glycogen Synthase Kinase 3 Alpha (GSK3a)
kl631Hu01 中期因子(MK)多克隆抗體 Polyclonal Antibody to Midkine (MK)
kl631Mu01 中期因子(MK)多克隆抗體 Polyclonal Antibody to Midkine (MK)
kl631Ra01 中期因子(MK)多克隆抗體 Polyclonal Antibody to Midkine (MK)
kl635Hu01 補(bǔ)體因子H(CFH)多克隆抗體 Polyclonal Antibody to Complement Factor H (CFH)
kl635Mu01 補(bǔ)體因子H(CFH)多克隆抗體 Polyclonal Antibody to Complement Factor H (CFH)
kl635Ra01 補(bǔ)體因子H(CFH)多克隆抗體 Polyclonal Antibody to Complement Factor H (CFH)
